BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38401353)

  • 1. External beam radiotherapy boost versus surgical debulking followed by radiotherapy for the treatment of metastatic lymph nodes in cervical cancer: A systematic review and meta-analysis.
    Bizzarri N; Di Berardino S; Benkortbi K; Balaya V; Gambacorta MA; Macchia G; Boulvain M; Feki A; Mathevet P; Lecuru F; Querleu D; Ferrandina G; Scambia G; Guani B
    Eur J Surg Oncol; 2024 Apr; 50(4):108013. PubMed ID: 38401353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic Debulking of Enlarged Pelvic Nodes during Surgical Para-aortic Staging in Locally Advanced Cervical Cancer: A Retrospective Comparative Cohort Study.
    Díaz-Feijoo B; Acosta Ú; Torné A; Gil-Ibáñez B; Hernández A; Domingo S; Gil-Moreno A;
    J Minim Invasive Gynecol; 2022 Jan; 29(1):103-113. PubMed ID: 34217852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
    Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
    J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.
    Olthof EP; Wenzel H; van der Velden J; Spijkerboer AM; Bekkers R; Beltman JJ; Nijman HW; Slangen B; Smolders R; van Trommel N; Zusterzeel PLM; Zweemer R; Stalpers LJA; van der Aa M; Mom C
    Int J Gynecol Cancer; 2022 Jul; 32(7):861-868. PubMed ID: 35483738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
    Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
    Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008217. PubMed ID: 21491407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
    Mezquita G; Muruzabal JC; Perez B; Aguirre S; Villafranca E; Jurado M
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():79-83. PubMed ID: 30889424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
    Fischer-Valuck BW; Rao YJ; Brenneman RJ; Patel PR; Filson CP; Jani AB; Liu Y; Goyal S; Xu K; Weiss A; Kucuk O; Cimmino C; Szabo S; Rossi P; Baumann BC; Pattaras J; Hershatter B; Patel SA
    Brachytherapy; 2020; 19(5):557-566. PubMed ID: 32624405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.
    Li L; Kou X; Feng X; Zhang M; Chao H; Wang L
    Radiat Oncol; 2015 Sep; 10():189. PubMed ID: 26377326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
    Adam JA; Arkies H; Hinnen K; Stalpers LJ; van Waesberghe JH; Stoker J; van Os R; Laan JJ; Mom CH; van Eck-Smit BL
    Q J Nucl Med Mol Imaging; 2018 Dec; 62(4):420-428. PubMed ID: 29869485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
    Lee YC; Rash DL; Stern RL; Mayadev JS
    Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Tiwari R; Narayanan GS; Reddy VP; Vishwanathan B; Narayanan S; Venugopal R
    Gynecol Oncol; 2021 Oct; 163(1):110-116. PubMed ID: 34304907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Liu R; Wang X; Tian JH; Yang K; Wang J; Jiang L; Hao XY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007563. PubMed ID: 25300170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
    He M; Guo M; Zhou Q; Tang Y; Zhong L; Liu Q; Fan X; Zhao X; Zhang X; Chen G; Shen Y; Xu Q; Chen X; Li Y; Zou D
    J Gynecol Oncol; 2023 May; 34(3):e55. PubMed ID: 36998225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
    Gultekin M; Beduk Esen CS; Balci B; Alanyali S; Akkus Yildirim B; Guler OC; Yuce Sari S; Ergen SA; Sahinler I; Alsan Cetin I; Onal C; Yildiz F; Ozsaran Z
    Int J Gynecol Cancer; 2021 Feb; 31(2):185-193. PubMed ID: 32998860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
    Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
    Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.